Adenocarcinoma of the Appendix - 170 Studies Found Estado Estudiar Completed Nombre del estudio: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condición: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Drug: TLR8 Agonist VTX-2337 Gi Completed Nombre del estudio: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condición: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Fecha: 2003-05-06 Intervenciones: Drug: paclitaxel Given IV Active, not recruiting Nombre del estudio: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Biological: Bevacizumab Given Completed Nombre del estudio: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Condición: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Drug: Carboplatin Given IV Recruiting Nombre del estudio: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición: Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Fecha: 2014-03-28 Intervenciones: Drug: Gemcitabine Hydrochloride Completed Nombre del estudio: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Suspended Nombre del estudio: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condición: Nausea and Vomiting Ovarian Brenner Tumor Ovarian Clear Ce Fecha: 2011-01-11 Intervenciones: Procedure: Adjuvant Therapy An Completed Nombre del estudio: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condición: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Fecha: 2009-10-09 Intervenciones: Drug: belinostat Given IV Completed Nombre del estudio: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condición: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Fecha: 2007-04-25 Intervenciones: Biological: sargramostim Given Completed Nombre del estudio: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condición: Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma Fecha: 2008-12-20 Intervenciones: Drug: Paclitaxel Given IV or i <<< Previous | Next >>>